Ipca Labs

65
Hold
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,766.85
84.6 (5.03%)
BSENSE

Aug 05, 03:30 PM

BSE+NSE Vol: 3.02 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Ipca Labs Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
1,572.00
1,131.00
842.00
745.00
1,135.00
1,388.00
Adjustment
277.00
727.00
489.00
235.00
195.00
183.00
Changes In working Capital
-293.00
-176.00
-91.00
48.00
-272.00
-236.00
Cash Flow after changes in Working Capital
1,555.00
1,682.00
1,240.00
1,029.00
1,058.00
1,335.00
Cash Flow from Operating Activities
1,141.00
1,321.00
944.00
805.00
856.00
1,090.00
Cash Flow from Investing Activities
-246.00
-869.00
-1,215.00
-725.00
-850.00
-520.00
Cash Flow from Financing Activities
-753.00
-282.00
-552.00
507.00
426.00
-305.00
Net Cash Inflow / Outflow
141.00
168.00
-823.00
588.00
431.00
263.00
Opening Cash & Cash Equivalents
924.00
755.00
1,578.00
990.00
559.00
295.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
1,066.00
924.00
755.00
1,578.00
990.00
559.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ipca Labs
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
1572.52
1377.65
195.00
14.15%
Adjustment
277.35
163.46
114.00
69.67%
Changes In working Capital
-293.95
-652.93
359.00
54.98%
Cash Flow after changes in Working Capital
1555.92
888.18
667.00
75.18%
Cash Flow from Operating Activities
1141.97
529.19
612.00
115.80%
Cash Flow from Investing Activities
-246.77
-428.92
182.00
42.47%
Cash Flow from Financing Activities
-753.53
-167.92
-586.00
-348.74%
Net Cash Inflow / Outflow
141.67
-67.65
208.00
309.42%
Opening Cash & Cash Equivalents
924.63
175.12
749.00
428.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
1066.3
107.47
959.00
892.18%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -13.57% vs 39.87% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,141.97
1,321.32
-13.57%